Mariana Verdelho Machado

ORCID: 0000-0001-7769-7860
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Diet, Metabolism, and Disease
  • Liver Disease and Transplantation
  • Diet and metabolism studies
  • Alcohol Consumption and Health Effects
  • Hedgehog Signaling Pathway Studies
  • Adipose Tissue and Metabolism
  • Liver physiology and pathology
  • Hepatitis C virus research
  • Pancreatitis Pathology and Treatment
  • Endoplasmic Reticulum Stress and Disease
  • Lipid metabolism and disorders
  • Celiac Disease Research and Management
  • Epigenetics and DNA Methylation
  • Genetic and Kidney Cyst Diseases
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Folate and B Vitamins Research
  • Hepatitis B Virus Studies
  • Gut microbiota and health
  • Pediatric Hepatobiliary Diseases and Treatments
  • Lipid metabolism and biosynthesis
  • Gastrointestinal disorders and treatments
  • Liver Diseases and Immunity
  • Parasites and Host Interactions
  • Cancer, Hypoxia, and Metabolism

University of Lisbon
2012-2024

Hospital Vila Franca de Xira
2020-2024

Hospital de Santa Maria
2012-2021

Centro Hospitalar Lisboa Norte
2016-2021

Instituto Nacional do Câncer
2021

Luzerner Kantonsspital
2020

University of Bern
2020

Duke Medical Center
2013-2018

Duke University
2012-2017

Duke University Hospital
2015

Several animal studies have emphasized the role of gut microbiota in nonalcoholic fatty liver disease (NAFLD). However, data about dysbiosis human NAFLD remain scarce literature, especially including whole spectrum lesions. We aimed to evaluate association between and severe lesions, that is, steatohepatitis (NASH) fibrosis, a well-characterized population adult NAFLD. Fifty-seven patients with biopsy-proven were enrolled. Taxonomic composition was determined using 16S ribosomal RNA gene...

10.1002/hep.28356 article EN Hepatology 2015-11-24

Background and aims Non-alcoholic steatohepatitis (NASH), the potentially progressive form of nonalcoholic fatty liver disease (NAFLD), is pandemic our time. Although there are several animal models NASH, consensus regarding optimal model lacking. We aimed to compare features NASH in two most widely-used mouse models: methionine-choline deficient (MCD) diet Western diet. Methods Mice were fed standard chow, MCD for 8 weeks, or (45% energy from fat, predominantly saturated with 0.2%...

10.1371/journal.pone.0127991 article EN cc-by PLoS ONE 2015-05-27

Recent evidence has linked obesity and the metabolic syndrome with gut dysbiota. The precise mechanisms underlying that association are not entirely understood; however, microbiota can enhance extraction of energy from diet regulate whole-body metabolism towards increased fatty acids uptake adipose tissue shift lipids oxidation to de novo production. Obesity high fat relate a specific microbiota, which is enriched in Firmicutes less Bacterioidetes. Microbiota also play role development...

10.1016/s1665-2681(19)31457-7 article EN cc-by-nc-nd Annals of Hepatology 2012-07-01

Smoothened (SMO), a coreceptor of the Hedgehog (Hh) pathway, promotes fibrogenic repair chronic liver injury. We investigated roles SMO+ myofibroblast (MF) in regeneration by conditional deletion SMO α smooth muscle actin (αSMA)+ cells after partial hepatectomy (PH).αSMA-Cre-ER(T2)×SMO/flox mice were treated with vehicle (VEH) or tamoxifen (TMX), and sacrificed 24-96 h post-PH. Regenerating livers analysed for proliferation, progenitors fibrosis qRT-PCR quantitative immunohistochemistry...

10.1136/gutjnl-2013-305962 article EN Gut 2013-10-30

Abstract microRNAs were recently suggested to contribute the pathogenesis of nonalcoholic fatty liver disease (NAFLD), a lacking specific pharmacological treatments. In that regard, nuclear receptors are arising as key molecular targets for treatment steatohepatitis (NASH). Here we show that, in typical model NASH-associated damage, microRNA-21 (miR-21) ablation results progressive decrease steatosis, inflammation and lipoapoptosis, with impairment fibrosis. complementary fast food (FF) diet...

10.1038/cddis.2017.172 article EN cc-by Cell Death and Disease 2017-04-13
Huai Zhang Giovanni Targher Christopher D. Byrne Seung Up Kim Vincent Wai-Sun Wong and 95 more Luca Valenti Myer Glickman Jaime Ponce Christos S. Mantzoros Javier Crespo Henning Grønbæk Wah Yang Mohammed Eslam Robert J. Wong Mariana Verdelho Machado Ming‐Lung Yu Omar M. Ghanem Takeshi Okanoue Junfeng Liu Yong‐ho Lee Xiao-Yuan Xu Qiuwei Pan Meili Sui Amedeo Lonardo Yusuf Yılmaz Liyong Zhu Christophe Moreno Luca Miele Monica Lupșor‐Platon Lei Zhao Teresa LaMasters Robert G. Gish Huijie Zhang Marius Nedelcu Wah‐Kheong Chan Mingfeng Xia Fernando Bril Junping Shi Christian Datz Stefano Romeo Jian Sun Dan Liu Silvia Sookoian Yimin Mao Nahúm Méndez‐Sánchez Xiaoyan Wang Nikolaos Pyrsopoulos Jian‐Gao Fan Yasser Fouad Dan‐Qin Sun Cosimo Giannini J. W. Chai Ze-Feng Xia Dae Won Jun Guojing Li Sombat Treeprasertsuk Yingxu Li Tan To Cheung Faming Zhang George Boon‐Bee Goh Masato Furuhashi Wai‐Kay Seto Hui Huang Anna Di Sessa Qinghong Li Εvangelos Cholongitas Le Zhang Themis Reverbel da Silveira Giada Sebastiani Leon A. Adams Wei Chen Xiaolong Qi Ivan Ranković Victor de Lédinghen Wenjie Lv Masahide Hamaguchi Radwan Kassir Dirk Müller‐Wieland Manuel Romero‐Gómez Ying Xu Yicong Xu Shiyao Chen Mohammad Kermansaravi Mohammad Shafi Kuchay Sander Lefere Chetan Parmar Gregory Y.H. Lip Chun‐Jen Liu Fredrik Åberg George Lau Jacob George Shiv Kumar Sarin Jingya Zhou Ming‐Hua Zheng Huai Zhang Giovanni Targher Christopher D. Byrne Seung Up Kim Vincent Wai-Sun Wong Luca Valenti

10.1007/s12072-024-10702-5 article EN Hepatology International 2024-06-15
Coming Soon ...